Biogen proposes acquisition of partner Sage Therapeutics - MSN
Sage Therapeutics (SAGE) Moves 35.1% Higher: Will This Strength Last? - Yahoo Finance
Biogen bid for Sage does not change narrative, says BMO Capital - Yahoo Finance
Sage Therapeutics takeover bid undervalues Zurzuvae, says Truist - Yahoo Finance
Biogen CEO sees no burning need for more acquisitions - Reuters
Biogen proposes acquisition of partner Sage Therapeutics - MSN
Biogen Wants to Buy Its Partner Sage for Almost No Premium - MSN
Biogen Offers to Buy Remaining Stake in Sage Therapeutics - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Shareholders to Learn More About the Investigation - AccessWire
Sage Therapeutics Stock Eyes Best Day In 5 Years On Biogen’s Unsolicited Bid: Retail Piles In - MSN

Pages